<DOC>
	<DOC>NCT01369758</DOC>
	<brief_summary>The objective of this study is to demonstrate the safety and effectiveness of community gynecologist initiated treatment of intra-uterine polyps and submucosal fibroids with the MyoSure Hysteroscopic Tissue Removal System in a significantly sized patient population.</brief_summary>
	<brief_title>MyoSure Hysteroscopic Tissue Removal System Registry Study</brief_title>
	<detailed_description>Between 500 and 600 subjects will be enrolled in a prospective, multi-center registry study. Approximately 100 of these cases will be completed in an office setting, with the remaining 400-500 cases completed in a hospital outpatient or ambulatory surgery center. Subjects will undergo a hysteroscopic tissue removal procedure to remove intrauterine polyps and submucosal fibroids.</detailed_description>
	<mesh_term>Leiomyoma</mesh_term>
	<mesh_term>Myofibroma</mesh_term>
	<criteria>1. Healthy female between 18 and 65 years of age 2. Subject must be able to understand, read and sign the study specific informed consent forms after the nature of the study has been fully explained to her 3. Subject is indicated for myomectomy or polypectomy 4. Subject exhibits intrauterine polyps and/or submucous myomas which meet one of the following criteria. In cases of subjects with multiple intrauterine pathology, classification is based as follows: All polyps All Type 0, Type 1 or Type 2 myomas ≤ 6 cm in diameter Polyps plus Type 0, Type 1 or Type 2 myomas ≤6 cm in diameter 1. Subject is pregnant 2. Subject has an IUD at the time of the procedure. A subject may be enrolled in the study if the IUD is removed prior to the treatment procedure 3. Subject is taking an anticoagulant or antiplatelet medication other than low dose aspirin 4. Active pelvic inflammatory disease or pelvic/vaginal infection 5. Subject has a known or suspected coagulopathy or bleeding disorder 6. Subject has a history of disease which increases the risk for fluid overload (i.e. significant cardiac, hepatic, or renal dysfunction) 7. Subject has other comorbid condition(s) that, in the opinion of the Investigator, could limit the subject's ability to participate in the study or impact the scientific integrity of the study</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>September 2012</verification_date>
	<keyword>morcellator</keyword>
	<keyword>hysteroscope</keyword>
	<keyword>myomectomy</keyword>
	<keyword>polypectomy</keyword>
	<keyword>uterine fibroids</keyword>
	<keyword>uterine polyps</keyword>
</DOC>